Skip to content

AARD AARD Shares (Diluted)

Shares (Diluted) at other companies

AbbVie logo
AbbVieABBV
1.8B+0.1%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
86.6M+185%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
68M+7.8%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
122.6M+28.4%
Viking Therapeutics logo
Viking TherapeuticsVKTX
115.6M+3.1%
Arvinas logo
ArvinasARVN
64M-12.0%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's shares (diluted)?
AARD (AARD) reported shares (diluted) of 21.8M in Q1 2026.
How has AARD's shares (diluted) changed year-over-year?
AARD's shares (diluted) increased by 65.3% year-over-year, from 13.2M to 21.8M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.